Home
Browse All Titles
Sign In
Browse All Titles
The Maudsley Prescribing Guidelines in Psychiatry
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
◀
*
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z
▶
View All
Iatrogenic dependence, benzodiazepines/z-drugs/gabapentinoids
Benzodiazepines, z-drugs and gabapentinoids: dependence, withdrawal effects and discontinuation
Benzodiazepine misuse
Illicit drugs
drugs of misuse summary
drug-induced excited state
interactions with prescribed psychotropic drugs
Iloperidone
Antidepressant-induced arrhythmia
Equivalent doses
Relative adverse effects - a rough guide
Antipsychotics - minimum effective doses
Quick reference for licensed maximum doses
immediate-release (IR) preparations
medication doses for older adults
attention deficit hyperactivity disorder treatments
modified release stimulant preparations preferred in adults
Immediate release versus extended release
Inappropriate sexual behaviour in older people
Infant exposure
Inhaled administration
antipsychotics
acutely disturbed/violent patients
Initiation schedules
Injections
In-patient detoxification, alcohol withdrawal
In pregnancy
first-generation
second-generation
Drug choice in pregnancy
neurodevelopment effects
Insomnia
melatonin use in children and adolescents
people living with human immunodeficiency virus
in pregnancy
menopausal women
Intentional non-adherence
Interactions with caffeine
international normalised ratio (INR), psychotropic agent effects
Interruptions in treatment
Interstitial nephritis
intracranial/intracerebral haemorrhage, SSRI risks
Impulsive behaviour, disinhibitory drug reactions, benzodiazepines
Incongruence of affect, multiple sclerosis
Initiation of risperidone ISM
Injectable diamorphine, prescribing guidelines for opioid dependency
In overdose
Integrase strand transfer inhibitors, psychiatric adverse reactions
Interactions between illicit drugs and psychotropics
interferons-a and Ã, psychiatric adverse effects
Interpreting sample results for drugs with established target ranges
Interstitial lung disease
Interventions for non-adherence
Refresh
first
prev
1
2
30
select
next
last
Displaying items 1 - 30 of 40